Abbott India — 360° view

Abbott India, a company in the Pharmaceuticals industry, reported revenue of ₹1,951 crore and net profit of ₹453 crore for the September 2026 quarter.

Abbott India (NSE: ABBOTINDIA) closed at ₹26,525.00 on 20 Nov 2026, down 10.3% over the past year. Its market capitalisation is ₹56,366 crore and it trades at 34.1 times earnings.

Share price
₹26,525.00 (20 Nov 2026)
Market cap
₹56,366 Cr (20 Nov 2026)
P/E
34.10 (20 Nov 2026)
Revenue
₹1,951 Cr (September 2026 quarter)
Net profit
₹453 Cr (September 2026 quarter)
ROCE
44.8% (FY26)
ROE
34.4% (FY26)
Book value
₹2,010 (FY26)
Dividend yield
2.47% (last 12 months to 20 Nov 2026)
52-week high / low
₹30,655.00 / ₹24,650.00 (20 Nov 2026)
1-year return
-10.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: ABBOTINDIA

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.